143:
183:
249:
referred to as microfluidic large-scale integration and branded IFCs. Richard DeLateur, a 20-year veteran of Intel®, came on as chief financial officer in 2006. Worthington was the company’s chief executive officer from its inception in 1999 to 2016. Quake has remained a member of the company’s
228:
Its proteomic analysis products are based on technology developed by DVS Sciences, acquired by
Fluidigm® in 2014. DVS is best known for its multiparameter single-cell protein analysis systems, which analyze antibody/metal complexes using atomic mass spectrometry. The technology enables precise,
273:
The company completed a successful initial public offering (IPO) in
February 2011, raising about $ 75 million. This followed a failed, ill-timed IPO in 2008. As of the 2011 IPO, Fluidigm had not yet become profitable. Following a $ 250 million investment from Casdin Capital, LLC and
253:
The company’s founders created integrated circuits that carried fluids rather than electrons. In 2009, the company was described as “the world’s leading manufacturer of microfluidic devices.” The company’s original microfluidics products were aimed for use in applications such as
204:
Standard BioTools sells products to academic research institutions; translational research and medical centers; cancer centers; clinical research laboratories; biopharmaceutical, biotechnology and plant and animal research companies; and contract research organizations.
232:
The company has remained a pioneer in integrated microfluidic technology, with continued iterations of IFCs for a growing variety of applications. It is also the only company developing mass cytometry technologies for both flow cytometry and imaging applications.
224:
or IFCs. Genomics applications using IFCs processed on the
Biomark™ X9 System for High-Throughput Genomics include gene expression and genotyping by PCR and NGS library preparation for pathogen detection, agrigenomics, sample identification and pharmacogenomics.
278:
LP in April 2022, Fluidigm changed its name to
Standard BioTools. This change in name emphasized their mission to create a diversified, scalable innovation-focused life science tools company serving the pharma research markets.
566:
197:, offers analytical mass cytometry systems for flow cytometry and tissue imaging, along with associated assays and reagents, as well as an automated genomic analysis instrument and a variety of microfluidic arrays, or
653:
658:
668:
663:
530:
673:
297:
In addition to its headquarters and laboratory facility in South San
Francisco, California, which it expanded in 2014, the company established the first
678:
625:
648:
443:
246:
425:
603:
213:
Standard BioTools is a public company traded on the NASDAQ stock exchange, previously under the ticker symbol FLDM, currently under
426:"Fluidigm and DVS Sciences Announce Agreement for Fluidigm to Acquire DVS Sciences – Creating a Single-Cell Technology Powerhouse"
621:
304:
In 2022, Standard BioTools expanded their offices and manufacturing and research and development facility in
Markham, Ontario.
108:
400:
201:, and consumables with fully kitted reagents. Custom assays and services are available with all systems and applications.
487:
548:
126:
567:"Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools"
461:
198:
267:
373:
275:
255:
130:
615:
Note: the book version viewed did not include the entire chapter cited here, only pages 225, 226 and 227.
345:
531:"Fluidigm Completes $ 250 Million Strategic Capital Infusion and Changes Name to Standard BioTools Inc"
512:
147:
245:
and Gajus
Worthington. The company was formed to commercialize technology developed by Quake at the
221:
599:
229:
high-parameter single-cell protein analysis for applications in life sciences research.
49:
642:
570:
242:
214:
57:
17:
70:
609:
595:
263:
75:
589:
588:
Angelescu, Dan E. (2011). "5.3.1 Microfluidic Large-Scale
Integration: Fludigm".
408:
259:
283:
294:
At the end of 2023, Standard BioTools had a headcount of 500 personnel.
182:
401:"Fluidigm: 250 Million Microfluidic Valves Manufactured – and Counting"
298:
66:
181:
16:"FLDM" redirects here. For the school in Nuevo LeĂłn, Mexico, see
620:
Linthwaite, Stephen
Christopher; Jog, Vikram (8 March 2022).
171:
654:
Technology companies based in the San
Francisco Bay Area
622:"Fluidigm Corporation 2021 Annual Report (Form 10-K)"
549:"New Name, New Investment, and New CEO for Fluidigm"
166:
156:
137:
119:
103:
85:
55:
45:
28:
659:Companies based in South San Francisco, California
513:"Fluidigm postpones IPO, citing market conditions"
241:The company was founded in 1999 as Mycometrix by
350:GEN - Genetic Engineering and Biotechnology News
301:manufacturing facility in Singapore in 2005.
331:
319:
8:
23:
22:
669:Technology companies established in 1999
626:U.S. Securities and Exchange Commission
346:"Fluidigm Pioneers Single-Cell Biology"
312:
664:American companies established in 1999
591:Highly Integrated Microfluidics Design
486:Del Conte, Natali T. (20 March 2006).
444:"Dvs Sciences Introduces The Cytof® 2"
286:in January 2024 in an all-stock deal.
462:"Mycometrix changes name to Fluidigm"
220:Its genomic analysis products create
7:
420:
418:
395:
393:
367:
365:
282:The company acquired NASDAQ-listed
247:California Institute of Technology
199:integrated fluidic circuits (IFCs)
14:
674:1999 establishments in California
142:
141:
535:Standard BioTools Press Release
448:Standard BioTools Press Release
430:Standard BioTools Press Release
405:Nanotechnology Business Journal
109:South San Francisco, California
679:Companies listed on the Nasdaq
488:"Richard DeLateur and Fludigm"
1:
407:. 7 Sep 2009. Archived from
594:. Integrated Microsystems.
344:Dutton, Gail (2015-01-14).
250:scientific advisory board.
91:; 25 years ago
18:Nuevo León § Education
695:
649:Research support companies
492:The San Francisco Examiner
372:Tse, Andrea (2011-02-10).
15:
374:"Fluidigm Pops After IPO"
332:Linthwaite & Jog 2022
320:Linthwaite & Jog 2022
186:Standard BioTools Canada
276:Viking Global Investors
256:protein crystallization
193:, previously known as
191:Standard BioTools Inc.
187:
24:Standard BioTools Inc.
466:Drug Discovery Online
185:
519:. 22 September 2008.
222:microfluidic devices
35:Fluidigm Corporation
162:615 (December 2021)
158:Number of employees
25:
573:. October 4, 2023.
188:
569:(Press release).
432:. 9 January 2014.
180:
179:
686:
629:
613:
575:
574:
563:
557:
556:
555:. 19 April 2024.
545:
539:
538:
527:
521:
520:
509:
503:
502:
500:
499:
483:
477:
476:
474:
473:
458:
452:
451:
440:
434:
433:
422:
413:
412:
411:on 2 April 2015.
397:
388:
387:
385:
384:
369:
360:
359:
357:
356:
341:
335:
329:
323:
317:
176:
173:
151:
145:
144:
125:Michael Egholm (
99:
97:
92:
26:
694:
693:
689:
688:
687:
685:
684:
683:
639:
638:
637:
632:
619:
606:
587:
583:
578:
565:
564:
560:
547:
546:
542:
537:. 4 April 2022.
529:
528:
524:
511:
510:
506:
497:
495:
485:
484:
480:
471:
469:
460:
459:
455:
442:
441:
437:
424:
423:
416:
399:
398:
391:
382:
380:
371:
370:
363:
354:
352:
343:
342:
338:
330:
326:
318:
314:
310:
292:
239:
211:
170:
159:
146:
122:
115:
111:
95:
93:
90:
81:
60:
41:
21:
12:
11:
5:
692:
690:
682:
681:
676:
671:
666:
661:
656:
651:
641:
640:
636:
635:External links
633:
631:
630:
617:
604:
584:
582:
579:
577:
576:
558:
540:
522:
504:
478:
453:
435:
414:
389:
361:
336:
324:
311:
309:
306:
291:
288:
238:
235:
210:
209:Business model
207:
195:Fluidigm Corp.
178:
177:
168:
164:
163:
160:
157:
154:
153:
139:
135:
134:
123:
120:
117:
116:
113:
107:
105:
101:
100:
87:
83:
82:
80:
79:
73:
63:
61:
56:
53:
52:
47:
43:
42:
40:
39:
36:
32:
30:
13:
10:
9:
6:
4:
3:
2:
691:
680:
677:
675:
672:
670:
667:
665:
662:
660:
657:
655:
652:
650:
647:
646:
644:
634:
627:
623:
618:
616:
611:
607:
605:9781596939806
601:
597:
593:
592:
586:
585:
580:
572:
571:GlobeNewswire
568:
562:
559:
554:
550:
544:
541:
536:
532:
526:
523:
518:
514:
508:
505:
493:
489:
482:
479:
468:. 4 June 2001
467:
463:
457:
454:
450:. 4 May 2013.
449:
445:
439:
436:
431:
427:
421:
419:
415:
410:
406:
402:
396:
394:
390:
379:
375:
368:
366:
362:
351:
347:
340:
337:
334:, p. 15.
333:
328:
325:
322:, p. 75.
321:
316:
313:
307:
305:
302:
300:
295:
289:
287:
285:
280:
277:
271:
269:
265:
261:
257:
251:
248:
244:
243:Stephen Quake
236:
234:
230:
226:
223:
218:
216:
208:
206:
202:
200:
196:
192:
184:
175:
169:
165:
161:
155:
150:130.6 million
149:
140:
136:
132:
128:
124:
118:
114:United States
110:
106:
102:
88:
84:
77:
74:
72:
68:
65:
64:
62:
59:
54:
51:
48:
44:
37:
34:
33:
31:
27:
19:
614:
610:Google Books
608:– via
596:Artech House
590:
561:
552:
543:
534:
525:
516:
507:
496:. Retrieved
494:. p. 17
491:
481:
470:. Retrieved
465:
456:
447:
438:
429:
409:the original
404:
381:. Retrieved
377:
353:. Retrieved
349:
339:
327:
315:
303:
296:
293:
281:
272:
264:DNA analysis
252:
240:
231:
227:
219:
212:
203:
194:
190:
189:
104:Headquarters
76:Russell 2000
46:Company type
553:Meddionline
172:standardbio
643:Categories
581:References
498:2023-12-11
472:2023-12-11
383:2023-12-11
355:2023-12-11
290:Operations
260:genotyping
121:Key people
38:Mycometrix
378:TheStreet
284:SomaLogic
127:president
78:component
58:Traded as
624:(XBRL).
29:Formerly
517:Reuters
299:biochip
237:History
167:Website
138:Revenue
94: (
86:Founded
69::
602:
152:(2021)
129:&
67:Nasdaq
50:Public
308:Notes
600:ISBN
266:and
174:.com
148:US$
96:1999
89:1999
268:PCR
215:LAB
131:CEO
71:LAB
645::
598:.
551:.
533:.
515:.
490:.
464:.
446:.
428:.
417:^
403:.
392:^
376:.
364:^
348:.
270:.
262:,
258:,
217:.
112:,
628:.
612:.
501:.
475:.
386:.
358:.
133:)
98:)
20:.
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
